Loading viewer...
earnings
Format: PDF earnings
Gilead Sciences presents Q2 2016 earnings results with financial commentary from executive leadership including CEO John Milligan and CFO Robin Washington. The presentation covers antiviral programs, HCV treatment products, and pipeline candidates including oncology and inflammation programs.
earnings
38 Pages
earnings
32 Pages
Instructure
Barrick Gold 2016 Q4 Results and 2017 Outlook
earningsearnings
35 Pages
Barrick Gold Corporation